Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Thumbnail

OTC Narcan will cost less than $50

The drug's manufacturer said it is working with retailers to get the drug on U.S. shelves and online for purchase by late summer.

Thumbnail

American College of Cardiology shares new HFpEF recommendations as cases continue to rise

HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible. 

bullish investments in healthcare AI

What healthcare AI investors have been saying at HIMSS23

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.

Thumbnail

Supreme Court delays final decision on abortion pill for 2 more days

A common abortion pill, mifepristone, is still in grave danger of being pulled off the market. 

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

FDA announces shift to simplify COVID-19 vaccines

The recommendation updates the FDA’s emergency use authorizations for the Moderna and Pfizer-BioNTech COVID-19 vaccines.

Cardiologist charged with multiple counts of sexual assault—police say there may be more victims

The doctor was charged with three counts of sexual assault related to an alleged date rape from January. A preliminary hearing has been scheduled for May. 

Internet of Things risky devices IP camera

The 6 riskiest medical and IoT devices deployed in healthcare

Among Internet of Things devices used in medical settings, Internet Protocol (IP) cameras are the most vulnerable to hackers. Meanwhile nurse call systems hold that troubling distinction among general medical devices.

Thumbnail

Moderna, Merck say new combination treatment boosts skin cancer survival

The new findings come after Moderna accused other pharmaceutical companies of stealing its mRNA technology for COVID-19 vaccines.